Diseases, Conditions, Syndromes

Study confirms longer-term lung damage after COVID-19

A study by Sheffield and Oxford researchers using a cutting-edge method of imaging has identified persistent damage to the lungs of COVID-19 patients at least three months after they were discharged from hospital, and for ...

Medications

New drugs to fight COVID-19 developed

Scientists from QIMR Berghofer Medical Research Institute in Queensland have developed two new drugs to both prevent SARS-CoV-2 infection, and also treat people who have been exposed to the virus so they do not develop severe ...

Vaccination

Slovak regulator voices misgivings about Sputnik vaccine

Slovakia's drug regulator said Thursday it was not able to determine the safety of a batch of Russia's Sputnik V vaccine delivered to Bratislava last month, voicing misgivings about its composition.

Medical research

Cancer discovery could revive failed treatments for solid tumors

New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately failed in human clinical trials.

Genetics

Scientists develop breath test for methylmalonic acidemia

Researchers at the National Institutes of Health have developed a breath test that measures how well patients with methylmalonic acidemia (MMA) respond to receiving liver or combined liver and kidney transplantation. Researchers ...

Diseases, Conditions, Syndromes

'Mop up' malaria vaccine advances to trials in people

University of Florida researcher Rhoel Dinglasan, Ph.D., was awarded $6 million today by the Global Health Innovative Technology Fund to test a new malaria vaccine in people. The process leading to a phase 1 clinical trial ...

page 23 from 40